non-clinical trial institute
Scope
Date
~
-
Banking & Finance
Korea's loan delinquency rates soar; outlook to worsen in H2
South Korean banks are seeing loan delinquency rates surge due to the increase in lending during the pandemic and a series of rate hikes. The rates ...
May 22, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korean Army opens Future & Innovation Research Center at KAIST
South Korean army announced that the Korea Army Research Center for Future & Innovation, a defense-related advanced science and technology resea...
May 22, 2023 (Gmt+09:00)
-
Artificial intelligence
Korean institutions eye investment in OpenAI at $40 bn valuation
OpenAI, the world’s most well-known artificial intelligence lab, is tapping South Korean institutional investors for investment at an estimate...
May 17, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Kyobo Life in final talks to buy Kakao Pay Insurance
South Korea’s third-largest life insurer Kyobo Life Insurance Co. is in the final stages of talks to buy Kakao Pay Insurance Corp., an online ...
May 09, 2023 (Gmt+09:00)
-
ASK 2023
Alternative investment forum ASK 2023 to kick off May 17 in Seoul
South Korean institutional investors, including the world’s third-largest pension fund National Pension Service (NPS), and global asset manage...
May 04, 2023 (Gmt+09:00)
-
Corporate governance
Hyosung’s sibling feud continues with second son in court on trial
It all began in July 2014 when Cho Hyun-joon, currently the Hyosung Group chairman, was sued by his younger brother Cho Hyun-moon on charges of embe...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Economy
S.Korea’s 20-somethings tighten belts due to high interest rates: report
The decline in consumption by 20-somethings due to benchmark interest rate hikes is over eight times greater than those in their 60s.Analysts blame ...
Apr 27, 2023 (Gmt+09:00)
-
Bio & Pharma
CG Bio establishes US corporation to develop tissue products
South Korean bio-regenerative medical firm CG Bio has launched a new US corporation CG MedTech, to focus on the development and marketing of tissue ...
Apr 25, 2023 (Gmt+09:00)
-
Electronics
Samsung faces $303 mn jury verdict in memory patent lawsuit in US
Samsung Electronics Co. lost a semiconductor patent infringement lawsuit filed in the US. The South Korean company received a jury verdict to pay ab...
Apr 23, 2023 (Gmt+09:00)
-
Bio & Pharma
AbClon shows promising results in clinical tests of leukemia treatment
South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...
Apr 19, 2023 (Gmt+09:00)
-
Electric vehicles
Samsung competes with Apple on rising non-terrestrial network market
The global market for non-terrestrial networks (NTN), or communications systems that use satellites to text and make phone calls even in places wher...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer
South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to use zebrafish in new drug development
South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...
Apr 10, 2023 (Gmt+09:00)
-
Private equity
Korean PE firm STIC taps Bain & Co senior partner for PE business
South Korean private equity firm STIC Investments Inc. is set to hire Lee Hyukjin, a senior partner of global management consulting firm Bain & ...
Apr 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit’s AI analysis solution client companies exceed 2,000
South Korean medical AI company Lunit announced on Tuesday that more than 2,000 medical institutions worldwide have adopted its AI-based diagnostic ...
Apr 04, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Korea's Hancom, Naver Cloud agree to cooperate in AI field
Hancom Inc. and Naver Cloud announced on Wednesday a strategic partnership to integrate Naver Cloud's large-scale artificial intelligence (AI) "Hype...
Mar 30, 2023 (Gmt+09:00)
-
Banking & Finance
Clearstream acquires QFI status from S.Korea's National Tax Service
Korea Securities Depository announced on Wednesday that Clearstream, the operator of the International Central Securities Depository (ICSD), had obt...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung, Axiom Space to set up JV to explore space healthcare options
South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...
Mar 21, 2023 (Gmt+09:00)
-
Cloud computing
Korea's LG CNS launches cloud cost optimization service
LG CNS, a South Korean company specializing in digital transformation, announced on Tuesday the launch of its new service called "FinOps" Clinic.Fin...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's FutureChem gets approval for phase 3 clinical trials in China
South Korean radiopharmaceutical development company FutureChem Co. announced on Thursday that China's National Medical Products Administration (NMP...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korean biotech NKMax’s unit aims for US IPO
NKMax Co., a South Korean cancer drug maker, is in talks with local and foreign investors in a bid to list its California-based unit NKGen Biotech I...
Mar 14, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
CGBio opens cosmetic surgery clinic in Bali using bio-medical tech
CGBio, a South Korean bio-renewable medical company, announced on Monday that it opened a medical esthetic clinic, called Nulook, in Bali, Indonesia...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
HYBE kicks off campaign to win over SM shareholders
Bang Si-hyuk, founder and chairman of the BTS label HYBE Co., has kicked off his campaign to gather support from institutional investors to take con...
Mar 09, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Upcoming IPOs
Korea’s sole foreign clinic operator CHA Healthcare to go public in 2025
CHA Healthcare Co. operating nearly 90 hospitals and infertility treatment centers across the world, is set to pave the way for South Koreans' inves...
Mar 08, 2023 (Gmt+09:00)
-
Robotics
Korea's SK Telecom jointly develops AI patrol robots
SK Telecom Co., along with its partner firms, will develop artificial intelligence (AI) robots that will replace security guards patrolling around s...
Mar 07, 2023 (Gmt+09:00)